Neurology

Pharma

Ionis scores ‘breakthrough’ rare disease approval

The FDA has approved Ionis' Zanvastro, the first medicine for Alexander disease and a first step in Ionis' journey to building a solo neuro franchise.

Darren Incorvaia Sep 4, 2026 11:18am

Servier revenue growth hits 16% as group eyes €10B 2030 goal

Jan 27, 2026 10:55am

AbbVie snaps up device plant amid broader $10B US investment

Jan 12, 2026 9:17am

Pharma’s reputation dips among neurology patient groups

Nov 3, 2025 12:50pm

Brain and money connected by a thread on a white background

Neurology patients call out pharma for inadequate investment

Nov 19, 2024 11:20am

Merz to expand and hunt for more deals after closing Inbrija buy

Jul 11, 2024 4:08pm